Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment

Drug and Alcohol Dependence

Volumn 137, Issue 1, 2014, Pages 29-35

  Gupta, Saurabh ^a,e   Iudicello, Jennifer E ^a   Shi, Chuan ^c   Letendre, Scott ^a   Knight, Adam ^a   Li, Jianhua ^f   Riggs, Patricia K ^a   Franklin, Donald R ^a   Duarte, Nichole ^a,e   Jin, Hua ^a,b   Hampton Atkinson, J ^a,b   Yu, Xin ^c   Wu, Zunyou ^d   Grant, Igor ^a   Heaton, Robert K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^d Center for Disease Control (CDC)   (China)

^e Gupta Psychology and Assessment Services   (United States)

^f Yunnan Institute of Drug Abuse   (China)

Author keywords

China; HCV; Injection drugs; Neurocognitive impairment

Indexed keywords

ALCOHOL; DIAMORPHINE; METHADONE;

ADULT; ALCOHOLISM; ARTICLE; CHINA; CHINESE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; LIVER FIBROSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; ASIAN CONTINENTAL ANCESTRY GROUP; COGNITION DISORDERS; DIAGNOSIS; ETHNOLOGY; OPIATE SUBSTITUTION TREATMENT; PSYCHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SUBSTANCE ABUSE; TREATMENT OUTCOME;

HEPATITIS C VIRUS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COGNITION DISORDERS; FEMALE; HEPATITIS C; HUMANS; MALE; METHADONE; NEUROPSYCHOLOGICAL TESTS; OPIATE SUBSTITUTION TREATMENT; RETROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 84896083326     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.12.021     Document Type: Article

References (50)

1. Avdoshina V., Biggio F., Palchik G., Campbell L.A., Mocchetti I. Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120. Glia 2010, 58:1630-1639.
2. Baldacchino A., Balfour D.J.K., Passetti F., Humphris G., Matthews K. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci. Biobehav. Rev. 2012, 36:2056-2068.
3. Beck A.T., Steer R.A., Ball R., Ranieri W.F. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J. Pers. Assess. 1996, 67:588-597.
4. Byrd D.A., Murray J., Safdieh G., Morgello S. Impact of opiate addiction on neuroinflammation in HIV. J. Neurovirol. 2012, 18:364-373.
5. Carey C.L., Woods S.P., Gonzalez R., Conover E., Marcotte T.D., Grant I., Heaton R.K. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J. Clin. Exp. Neuropsychol. 2004, 26:307-319.
6. Cherner M., Letendre S.L., Heaton R.K., Durelle J., Marquie-Beck J., Gragg B., Grant I. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 2005, 64:1343-1347.
7. Curran H.V., Kleckham J., Bearn J., Strang J., Wanigaratne S. Effects of methadone on cognition, mood, and craving in detoxifying opiate addicts: a dose-response study. Psychopharmacology 2001, 154:153-160.
8. Cysique L.A., Jin H., Franklin D.R., Morgan E.E., Shi C., Yu X., Shi C., Yu X., Wu Z., Taylor M.J., Marcotte T.D., Letendre S., Ake C., Grant I., Heaton R.K. Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. J. Int. Neuropsychol. Soc. 2007, 13:781-790. the HNRC Group.
9. Cysique L.A., Letendre S.L., Ake C., Jin H., Franklin D.R., Gupta S., Shi C., Yu X., Wu Z., Abramson I.S., Grant I., Heaton R.K. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS 2010, 24:983-990.
10. Darke S., Sims J., McDonald S., Wickes W. Cognitive impairment among methadone maintenance patients. Addiction 2000, 95:687-695.
11. Ellis R.J., Joseph J., de Almeida S.M. NeuroAIDS in Brazil. J. Neurovirol. 2007, 13:89-96.
12. Fishman S.L., Murray J.M., Eng F.J., Walewski J.L., Morgello S., Branch A.D. Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J. Infect. Dis. 2008, 197:597-607.
13. Grover V.P., Pavese N., Koh S.B., Wylezinska M., Saxby B.K., Gerhard A., Forton D.M., Brooks D.J., Thomas H.C., Taylor-Robinson S.D. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J. Viral Hepat. 2012, 19:e89-e96.
14. Gruber S.A., Silveri M.M., Yurgelun-Todd D.A. Neuropsychological consequences of opiate use. Neuropsychol. Rev. 2007, 17:299-315.
15. Hao W., Xiao S., Liu T., Young D., Chen S., Zhang D., Li C., Shi J., Chen G., Yang K. The second National Epidemiological Survey on illicit drug use at six high-prevalence areas in China: prevalence rates and use patterns. Addiction 2002, 97:1305-1315.
16. Heaton R.K., Clifford D.B., Franklin D.R., Woods S.P., Ake C., Vaida F., Ellis R.J., Letendre S.L., Marcotte T.D., Atkinson J.H., Rivera-Mindt M., Vigil O.R., Taylor M.J., Collier A.C., Marra C.M., Gelman B.B., McArthur J.C., Morgello S., Simpson D.M., McCutchan J.A., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010, 75:2087-2096. the CHARTER Group.
17. Heaton R.K., Cysique L.A., Jin H., Shi C., Yu X., Letendre S., Franklin D.R., Ake C., Vigil O., Atkinson J.A., Marcotte T.D., Grant I., Wu Z. Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J. Neurovirol. 2008, 14:536-549. the HNRC Group.
18. Heaton R.K., Miller W., Taylor M.J., Grant I. Revised Comprehensive Norms for an Expanded Halstead Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults 2004, Psychological Assessment Resources, Lutz, FL.
19. Hestad K.A., Menon J.A., Silalukey-Ngoma M., Franklin D.R., Imasiku M.L., Kalima K., Heaton R.K. Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia, Africa. J. Nerv. Ment. Dis. 2012, 200:336-342.
20. Hilsabeck R.C., Hassanein T.I., Carlson M.D., Ziegler E.A., Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J. Int. Neuropsychol. Soc. 2003, 9:847-854.
21. Hilsabeck R.C., Perry W., Hassanein T.I. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002, 35:440-446.
22. Joseph J., Achim C.L., Boivin M., Brew B.J., Clifford D., Colosi D.A., Ellis R.J., Heaton R.K., Gallo-Diop A., Grant I., Kanmogne G.D., Kumar M., Letendre S., Marcotte T.D., Nath A., Pardo C.A., Paul R.H., Pulliam L., Robertson K., Royal W., Sacktor N., Sithinamsuwan P., Smith D.M., Valcour V., Wigdahl B., Wood C. Global neuroAIDS rountable. J. Neurovirol. 2013, 19:1-9.
23. Kamat R., Ghate M., Gollan T.H., Meyer R., Vaida F., Heaton R.K., Letendre S., Franklin D., Alexander T., Grant I., Mehendale S., Marcotte T.D. Effects of Marathi-Hindi bilinguialism on neuropsychological performance. J. Int. Neuropsychol. Soc. 2012, 18:305-315. the HNRP Group.
24. Kanmogne G.D., Kuate C.T., Cysique L.A., Fonsah J.Y., Eta S., Doh R., Njamnshi D.M., Nchindap E., Franklin D.R., Ellis R.J., McCutchan J.A., Binam F., Mbanya D., Heaton R.K., Njamnshi A.K. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol. 2010, 10:60.
25. Kessler R.C., Ustun T.B. The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int. J. Methods Psychiatr. Res. 2004, 13:93-121.
26. Lyvers M., Yakimoff M. Neuropsychological correlates of opioid dependence and withdrawal. Addict. Behav. 2003, 28:605-611.
27. Maggi F., Fornai C., Morrica A., Vatteroni M.L., Giorgi M., Marchi S., Ciccorossi P., Bendinelli M., Pistello M. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. J. Med. Virol. 1999, 57:57-63.
28. Maggi F., Giorgi M., Fornai C., Morrica A., Vatteroni M.L., Pistello M., Siciliano G., Nuccorini A., Bendinelli M. Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J. Neurovirol. 1999, 5:319-323.
29. Mintzer M.Z., Stitzer M.L. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend. 2002, 67:41-51.
30. Mitrovic S.M., Dickov A., Vuckovic N., Mitrovic D., Budisa D. The effect of heroin on verbal memory. Psychiatr. Danub. 2011, 23:53-59.
31. Morgan E.E., Woods S.P., Rooney A., Perry W., Grant I., Letendre S.L. Hepatitis C (HCV) impacts neurocognitive dispersion: greater within-person variability across cognitive domains among HCV-seropositive individuals. Arch. Clin. Neuropsychol. 2011, 26:491.
32. Njamnshi A.K., Bissek A.C., Ongolo-Zogo P., Tabah E.N., Lekoubou A.Z., Yepnjio F.N., Fonsah J.Y., Kuate C.T., Angwafor S.A., Dema F., Njamnshi D.M., Kouanfack C., Djientcheu, Vde P., Muna W.F., Kanmogne G.D. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaounde-Cameroon. J. Neurol. Sci. 2009, 285:149-153.
33. Rippeth J.D., Heaton R.K., Carey C.L., Marcotte T.D., Moore D.J., Gonzalez R., Wolfson T., Grant I. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J. Int. Neuropsychol. Soc. 2004, 10:1-14. the HNRC Group.
34. Royal W., Cherner M., Carr J., Habib A.G., Akomolafe A., Abimiku A., Charurat M., Farley J., Oluyemisi A., Mamadu I., Johnson J., Ellis R., McCutchan J.A., Grant I., Blattner W.A. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. J. Neurovirol. 2012, 18:191-199.
35. Schaefer M., Capuron L., Friebe A., Diez-Quevedo C., Robaeys G., Neri S., Foster G.R., Kautz A., Forton D., Pariante C.M. Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement. J. Hepatol. 2012, 57:1379-1390.
36. Schrier R.D., Gupta S., Riggs P.K., Cysique L.A., Letendre S., Jin H., Spector S.A., Singh K.K., Wolfson T., Wu Z., Hong K.X., Shi C., Heaton R.K. The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China. PLoS ONE 2012, 7:e32303. the HNRC Group.
37. Senzolo M., Schiff S., D'Aloiso C.M., Crivellin C., Cholongitas E., Burra P., Montagnese S. Neuropsychological alterations in hepatitis C infection: the role of inflammation. World J. Gastroenterol. 2011, 17:3369-3374.
38. Soyka M., Lieb M., Kagerer S., Zingg C., Koller G., Lehnert P., Limmer C., Heinrich K., Hennig-Fast K. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial. J. Clin. Psychopharmacol. 2008, 28:699-703.
39. Soyka M., Limmer C., Lehnert R., Koller G., Martin G., Kufner H., Kagerer S., Haberthur A. A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot study. Am. J. Drug Alcohol Abuse 2011, 37:497-508.
40. Spector S.A., Singh K.K., Gupta S., Cysique L.A., Jin H., Letendre S., Schrier R., Wu Z., Hong K.X., Yu X., Shi C., Heaton R.K. 195APOE e4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors from Anhui Province, China. AIDS 2010, 24:1471-1479. the HNRC Group.
41. Spies G., Fennema-Notestine C., Archibald S.L., Cherner M., Seedat S. Neurocognitive deficits in HIV-infected women and victims of childhood trauma. AIDS Care 2012, 24:1126-1135.
42. Sterling R.K., Lissen E., Clumeck N., Sola R., Correa M.C., Montaner J., Sulkowski M.S., Torriani F.J., Dieterich D.T., Thomas D.L., Messinger D., Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006, 43:1317-1325.
43. Tanaka M., Katayama F., Kato H., Tanaka H., Wang J., Qiao Y.L., Inoue M. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J. Epidemiol. 2011, 21:401-416.
44. Taylor M.K., Heaton R.K. Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment. J. Int. Neuropsychol. Soc. 2001, 7:867-874.
45. Verdejo A., Toribio I., Orozco C., Puente K.L., Perez-Garcia M. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend. 2005, 78:283-288.
46. Verdejo-Garcia A.J., Perez-Garcia M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology 2007, 190:517-530.
47. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., Lok A.S. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
48. World Health Organization Composite International Diagnostic Interview, Version 2.1 1997, World Health Organization, Geneva.
49. Yan Z., Fan K., Wang Y., Fan Y., Tan Z., Deng G. Changing pattern of clinical epidemiology on hepatitis C virus infection in Southwest China. Hepat. Mon. 2012, 12:196-204.
50. Zheng Y. Application of BDI in depressive neurosis. Chin. J. Psychiatry 1987, 13:236-237.